Royal Bank of Canada’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5K | Buy |
+1,558
| New | +$5.54K | ﹤0.01% | 6927 |
|
|
2023
Q4 | – | Sell |
-56
| Closed | – | – | 7164 |
|
|
2023
Q3 | $0 | Hold |
56
| – | – | ﹤0.01% | 7131 |
|
|
2023
Q2 | $0 | Sell |
56
-9
| -14% | -$17 | ﹤0.01% | 7295 |
|
|
2023
Q1 | $0 | Hold |
65
| – | – | ﹤0.01% | 7108 |
|
|
2022
Q4 | $0 | Buy |
65
+9
| +16% | +$20 | ﹤0.01% | 7271 |
|
|
2022
Q3 | $0 | Sell |
56
-52
| -48% | -$158 | ﹤0.01% | 7484 |
|
|
2022
Q2 | $0 | Buy |
108
+18
| +20% | +$63 | ﹤0.01% | 7399 |
|
|
2022
Q1 | $0 | Sell |
90
-4,886
| -98% | -$26.9K | ﹤0.01% | 7765 |
|
|
2021
Q4 | $41K | Sell |
4,976
-8,835
| -64% | -$86.8K | ﹤0.01% | 6479 |
|
|
2021
Q3 | $175K | Buy |
13,811
+7,053
| +104% | +$97.7K | ﹤0.01% | 5288 |
|
|
2021
Q2 | $105K | Sell |
6,758
-408
| -6% | -$6.86K | ﹤0.01% | 5570 |
|
|
2021
Q1 | $146K | Buy |
7,166
+1,926
| +37% | +$47.6K | ﹤0.01% | 5170 |
|
|
2020
Q4 | $142K | Sell |
5,240
-12,983
| -71% | -$291K | ﹤0.01% | 5110 |
|
|
2020
Q3 | $337K | Buy |
18,223
+13,895
| +321% | +$247K | ﹤0.01% | 4166 |
|
|
2020
Q2 | $77K | Buy |
4,328
+3,228
| +293% | +$49.1K | ﹤0.01% | 5008 |
|
|
2020
Q1 | $10K | Hold |
1,100
| – | – | ﹤0.01% | 5823 |
|
|
2019
Q4 | $19K | Sell |
1,100
-150
| -12% | -$2K | ﹤0.01% | 5866 |
|
|
2019
Q3 | $13K | Sell |
1,250
-719
| -37% | -$9.67K | ﹤0.01% | 5673 |
|
|
2019
Q2 | $30K | Buy |
1,969
+293
| +17% | +$5.23K | ﹤0.01% | 5506 |
|
|
2019
Q1 | $31K | Buy |
1,676
+45
| +3% | +$798 | ﹤0.01% | 5414 |
|
|
2018
Q4 | $26K | Buy |
1,631
+531
| +48% | +$12.3K | ﹤0.01% | 5449 |
|
|
2018
Q3 | $31K | Buy |
1,100
+495
| +82% | +$14.2K | ﹤0.01% | 5452 |
|
|
2018
Q2 | $17K | Sell |
605
-1,611
| -73% | -$48K | ﹤0.01% | 5603 |
|
|
2018
Q1 | $70K | Buy |
2,216
+1,836
| +483% | +$58K | ﹤0.01% | 4884 |
|
|
2017
Q4 | $11K | Hold |
380
| – | – | ﹤0.01% | 5821 |
|
|
2017
Q3 | $11K | Sell |
380
-515
| -58% | -$13.3K | ﹤0.01% | 6222 |
|
|
2017
Q2 | $23K | Buy |
895
+725
| +426% | +$17.3K | ﹤0.01% | 5481 |
|
|
2017
Q1 | $4K | Hold |
170
| – | – | ﹤0.01% | 6271 |
|
|
2016
Q4 | $3K | Sell |
170
-1,000
| -85% | -$18.5K | ﹤0.01% | 6404 |
|
|
2016
Q3 | $28K | Hold |
1,170
| – | – | ﹤0.01% | 5409 |
|
|
2016
Q2 | $31K | Sell |
1,170
-100
| -8% | -$2.93K | ﹤0.01% | 5312 |
|
|
2016
Q1 | $35K | Buy |
1,270
+1,100
| +647% | +$26.5K | ﹤0.01% | 5275 |
|
|
2015
Q4 | $5K | Buy |
170
+70
| +70% | +$2.12K | ﹤0.01% | 6144 |
|
|
2015
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 6295 |
|
|
2015
Q2 | $4K | Buy |
+100
| New | +$3.51K | ﹤0.01% | 6273 |
|
Other funds holding CLLS
BGI
LFCM
NAMI
Royal Bank of Canada's CLLS Position: Q2 2026 in Review
Royal Bank of Canada opened a new position in Cellectis (CLLS) in Q2 2026: 1,558 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #6927 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in CLLS as recently as Q3 2023.
Royal Bank of Canada first reported a position in CLLS in Q2 2015 and has held it in 35 quarters since. The position peaked at $337K in Q3 2020. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.
- Royal Bank of Canada held 1,558 shares of Cellectis worth $5K as of Q2 2026.
- Cellectis was a new Royal Bank of Canada position in Q2 2026.
- Cellectis made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6927 holding.
- Royal Bank of Canada first reported a position in Cellectis in Q2 2015 and has held it in 35 quarters since.
- Royal Bank of Canada's Cellectis position peaked at $337K in Q3 2020.
- 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.